Michael Bruckman/LinkedIn
Dec 17, 2025, 05:54
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn:
”Fantastic to see platelet-inspired nanoparticles gaining attention!
This work with Case Western Reserve University and Haima Therapeutics demonstrates how targeted drug delivery at sites of injury can dramatically improve outcomes; in this case, enhancing implanted electrode performance.
Excited about the broad potential of this platform, from neuroscience to trauma care and beyond.”
Read the full article here.
Article: Platelet-inspired nanoparticle delivers drugs directly where they are needed
Authors: Julia Rock-Torcivia
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause